Hostname: page-component-6bf8c574d5-8gtf8 Total loading time: 0 Render date: 2025-02-23T01:34:47.621Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology of Vancomycin-Resistant Enterococci with Reduced Susceptibility to Daptomycin

Published online by Cambridge University Press:  02 January 2015

Theresa Judge ,
Jason M. Pogue ,
Dror Marchaim ,
Kevin Ho ,
Srinivasa Kamatam ,
Shakila Parveen ,
Namita Tiwari ,
Priyanka Nanjireddy ,
Suchitha Bheemreddy  and
Caitlin Biedron
...Show all authors
Theresa Judge
Affiliation:
Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan
Jason M. Pogue
Affiliation:
Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan
Dror Marchaim
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Kevin Ho
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Srinivasa Kamatam
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Shakila Parveen
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Namita Tiwari
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Priyanka Nanjireddy
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Suchitha Bheemreddy
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Caitlin Biedron
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Sagar Mallikethi Lepakshi Reddy
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Vijaykumar Khammam
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Indu K. Chalana
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Rajachendra Shekher Tumma
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Vicki Collins
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Adnan Yousuf
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Paul R. Lephart
Affiliation:
Detroit Medical Center University Laboratories, Detroit, Michigan
Emily T. Martin
Affiliation:
Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan
Michael J. Rybak
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan
Keith S. Kaye
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
Kayoko Hayakawa*
Affiliation:
Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan
*
Harper University Hospital, 3990 John R Street, Detroit, MI 48084 (kayokohayakawa@gmail.com)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A retrospective case–case control study was conducted, including 60 cases with daptomycin-nonsusceptible vancomycin-resistant enterococci (DNS-VRE) matched to cases with daptomycin-susceptible VRE and to uninfected controls (1:1:3 ratio). Immunosuppression, presence of comorbid conditions, and prior exposure to antimicrobials were independent predictors of DNS-VRE, although prior daptomycin exposure occurred rarely. In summary, a case–case control study identified independent risk factors for the isolation of DNS-VRE: immunosuppression, multiple comorbid conditions, and prior exposures to cephalosporines and metronidazole.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 12 , December 2012 , pp. 1250 - 1254
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

References

1.Canton, R, Ruiz-Garbajosa, P, Chaves, RL, Johnson, AP. A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother 2010;65:1126–1136.Google Scholar
2.Kelesidis, T, Humphries, R, Uslan, DZ, Pegues, DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 2011;52:228–234.Google Scholar
3.Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.Google Scholar
4.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobia Susceptibility Testing: Nineteenth Informational Supplement. Wayne, PA: CLSI; 2009. CLSI document M100-S19.Google Scholar
5.Kamboj, M, Cohen, N, Gilhuley, K, Babady, NE, Seo, SK, Sepkowitz, KA. Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 2011;32:391–394.Google Scholar
6.Munoz-Price, LS, Lolans, K, Quinn, JP. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis 2005;41:565–566.Google Scholar
7.Arias, CA, Panesso, D, McGrath, DM, et al.Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011;365:892–900.Google Scholar
8.Dade, Behring. MicroScan Dried Gram Positive Panels 2011–04 Enterococcus faecium with Reduced Susceptibility to Daptomycin. Technical Support Bulletin 182. Sacramento, CA: Dade Behring, 2011.Google Scholar
9.Palavecino, EL, Schoppe, CH. Discrepancies between daptomycin susceptibility results by MicroScan panel PC29 and by E test in S. aureus and enterococci. The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago; 2011.Google Scholar